Reminder3 Apr 2025 12:50
"This new discovery, conducted by the Company's R&D subsidiary ImmuPharma Biotech, has yielded data that provides novel insights into autoimmune disease mechanisms. Through this research, the Company is making a significant step towards personalised medicine in SLE and other autoimmune diseases".
We just need to know what those steps are toward personalised medicines. Will P140 beneficial for those with symptoms that are now being treated with Prednisolone? We know Prednisolone treats inflammatory types of arthritis, such as rheumatoid arthritis, and related diseases such as gout, lupus, and vasculitis. It's also used to treat many other conditions, from allergies and asthma to cancer and multiple sclerosis symptoms.
If P140 is expected to be successful for people with Lupus. And other conditions. So could it complete with Prednisolone?
This is a $6-7 Billion market alone. 1/10 of this would be pretty big. If IMM breakthrough is as good as Tim thinks it could be very big. Will it or could it be an alternative to Prednisolone?
Actually we need to know more about P140 and more about this breakthrough. I am informed that Prednisolone is sometimes used for some Cancer's. How about P140?